The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons.
It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
Antiviral resistance testing in the management of hepatitis C virus infection
Download
This report from the Public Health England Hepatitis C Virus Resistance Group to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.
